Subretinal hyperreflective material, or SHRM, is a bright layer of tissue between the neurosensory retina and the retinal pigment epithelium on OCT.

It appears in many eyes with neovascular AMD, and it can represent vessels, fibrin, blood, lipid, or scar. Its presence and persistence affect prognosis, so it deserves careful attention.


What Subretinal Hyperreflective Material Is

SHRM is a descriptive term, not a diagnosis, and it includes several tissue types that look similar on OCT: neovascular complexes, fibrin, hemorrhage, vitelliform deposits, and fibrotic scar.

Because the content differs, the response to treatment differs as well. Clinicians use other imaging to separate the types (see macular neovascularization types).

Subretinal Hyperreflective Material in CATT

The Comparison of AMD Treatments Trials analyzed SHRM in detail. Willoughby and colleagues found that SHRM was common at baseline, and it correlated with worse vision at baseline and at two years.

Eyes with SHRM at baseline had a higher risk of scar formation, and its presence at follow-up predicted worse acuity. Jaffe and colleagues reported similar patterns in year five of the trial.

Test your knowledge 10 questions from this article
Choroida · Fundus imaging

Fundus Explorer Pro

Photograph the retinal findings described here with the phone already in your pocket — 22 D optics and built-in illumination in one handheld unit.

From Choroida — the team behind this site

Differential Diagnosis of Subretinal Hyperreflective Material

  • Active neovascularization with fibrovascular tissue
  • Subretinal fibrin from exudation or hemorrhage
  • Acute vitelliform material in pattern dystrophies
  • Subretinal scar after long-standing disease

Use OCT angiography, fluorescein angiography, and color photographs to identify the source (see submacular hemorrhage management).

Management of Subretinal Hyperreflective Material

Continue anti-VEGF therapy when SHRM reflects active neovascular tissue or exudation. Fibrin and hemorrhage may clear with treatment, and in some eyes the material shrinks over months.

When the material is a scar, additional injections offer little benefit, and visual aids may help. Combination therapy and surgery have a role in selected eyes with thick submacular blood (see anti-VEGF therapy).

Prognosis of Subretinal Hyperreflective Material

The size and the thickness of the material matter, and a thick lesion beneath the fovea carries a worse outlook. Early and sustained treatment lowers the risk of fibrosis, though it cannot prevent it in every eye. Document the presence of SHRM at baseline, and follow its changes with each visit.

Practical Points

  • Compare current scans with the baseline instead of only the last visit
  • Correlate OCT findings with angiography
  • Explain to patients that some material may remain after treatment

An Example Case

A 77-year-old woman starts anti-VEGF therapy for neovascular AMD with acuity of 20/100. OCT shows a thick layer of subretinal hyperreflective material and a small pigment epithelial detachment.

After six monthly injections, the fluid resolves and the material becomes thinner, with a stable border, and vision improves to 20/60, though a patch of material persists. Follow-up shows a fibrotic scar that stays stable on a longer interval.

Subretinal Hyperreflective Material on OCT

Questions Patients Ask

Patients ask whether the material is scar tissue, and the answer is that it may be a mix of blood, fibrin, and tissue. They also ask whether injections will remove it, and some material shrinks while scar remains. Because outcomes differ, explain the plan and the goal of keeping vision stable.

Pitfalls to Avoid

  • Calling every hyperreflective area a scar
  • Stopping treatment because of persistent material without checking for fluid
  • Skipping angiography when the diagnosis is uncertain
  • Overlooking submacular blood that needs urgent care

Looking Ahead

Artificial intelligence may separate fibrin, vessels, and scar automatically, and new drugs may reduce fibrosis. Until then, follow the material with careful OCT reading.

Practical Points

Compare the width and the height of the material at each visit. Then note changes in the retinal pigment epithelium and the outer retina, and record whether fluid accompanies the material.

Choosing Imaging for Subretinal Hyperreflective Material

OCT angiography shows flow within the material when vessels are present, while fluorescein angiography shows leakage and staining. Because both tests give different information, choose by the clinical question, and also use autofluorescence to detect blood and fibrin, which may look different from scar.

Documenting Subretinal Hyperreflective Material

Record the height, the width, and the location relative to the fovea, then compare the dimensions over time. Finally, note whether the material is increasing, stable, or shrinking. Explain that scars may keep vision low, even when the macula stays dry.

Communicating With Patients

Show the OCT and point out the area of material, then explain that treatment aims to keep the retina stable. Because many patients expect a full recovery, describe realistic goals and remind them to report new distortion promptly.


All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References

  1. Willoughby AS, Ying GS, Toth CA, et al. Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2015;122:1846-1853.
  2. Daniel E, Toth CA, Grunwald JE, et al. Risk of scar in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 2014;121:656-666.
  3. Jaffe GJ, Ying GS, Toth CA, et al. Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 2019;126:252-260.
  4. American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous. AAO; current edition.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. On OCT, where does subretinal hyperreflective material (SHRM) lie?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.